Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 8,210 shares at $24.10 ($198K) on 2025-01-08, disclosed to the SEC on 2025-01-10.
Seasonal sale ($198k) by Chief Financial Officer — this insider has traded IMVT in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.10 | 4,105 | $99K | 50.0% |
| 2 | $24.10 | 4,105 | $99K | 50.0% |
| Total | $24.10 avg | 8,210 | $198K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $212K | — | Filing → |